医药前沿
醫藥前沿
의약전연
YIAYAO QIANYAN
2013年
31期
150-151
,共2页
尿N-乙酰-β-D-氨基葡萄糖苷酶%早期肾损伤
尿N-乙酰-β-D-氨基葡萄糖苷酶%早期腎損傷
뇨N-을선-β-D-안기포도당감매%조기신손상
Urinary NAG%Early renal injury
目的:探讨尿N-乙酰-β-D-氨基葡萄糖苷酶(NAG)检测对早期肾损害的诊断价值及临床意义。方法分别对我院340例住院患者和40例健康体检者进行尿NAG、尿微量白蛋白(MALB)、β2-微球蛋白(β2-MG)、α1-微球蛋白(α1-MG)检测。结果340例住院患者中124例患者标本NAG检测结果显著高于健康对照组;87例患者标本β2-MG检测结果显著高于健康对照组;64例患者标本α1-MG检测结果显著高于健康对照组;46例患者标本MALB检测结果显著高于健康对照组。结论尿NAG检测对于早期肾损害的灵敏度优于尿β2-MG、尿α1-MG和尿MALB。对于临床早期发现患者肾损害有一定提示作用,值得临床推广。
目的:探討尿N-乙酰-β-D-氨基葡萄糖苷酶(NAG)檢測對早期腎損害的診斷價值及臨床意義。方法分彆對我院340例住院患者和40例健康體檢者進行尿NAG、尿微量白蛋白(MALB)、β2-微毬蛋白(β2-MG)、α1-微毬蛋白(α1-MG)檢測。結果340例住院患者中124例患者標本NAG檢測結果顯著高于健康對照組;87例患者標本β2-MG檢測結果顯著高于健康對照組;64例患者標本α1-MG檢測結果顯著高于健康對照組;46例患者標本MALB檢測結果顯著高于健康對照組。結論尿NAG檢測對于早期腎損害的靈敏度優于尿β2-MG、尿α1-MG和尿MALB。對于臨床早期髮現患者腎損害有一定提示作用,值得臨床推廣。
목적:탐토뇨N-을선-β-D-안기포도당감매(NAG)검측대조기신손해적진단개치급림상의의。방법분별대아원340례주원환자화40례건강체검자진행뇨NAG、뇨미량백단백(MALB)、β2-미구단백(β2-MG)、α1-미구단백(α1-MG)검측。결과340례주원환자중124례환자표본NAG검측결과현저고우건강대조조;87례환자표본β2-MG검측결과현저고우건강대조조;64례환자표본α1-MG검측결과현저고우건강대조조;46례환자표본MALB검측결과현저고우건강대조조。결론뇨NAG검측대우조기신손해적령민도우우뇨β2-MG、뇨α1-MG화뇨MALB。대우림상조기발현환자신손해유일정제시작용,치득림상추엄。
Objective: To explore diagnostic value of urinary NAG in early renal injury . Methods: 340 cases in our hospital patients and 40 healthy subjects for urinary NAG, urinary albmin(MALB),β2-microglobulin(β2-MG),a1-microglobulin(a1-MG) detection. Results:In 340 cases of hospitalized patients, 120 patients specimens NAG test results were significantly higher than the healthy controls group; 87 patients specimensβ2-MG test results were significantly higher than the healthy controls group; 64 patients specimens a1-MG test results were significantly higher than the healthy controls group; 46 patients specimens MALB test results were significantly higher than the healthy control group. Conclusion: Urinary NAG detection sensitivity for early renal damage than urinary β2-MG, urinary a1-MG and urine MALB. For clinical renal damage in patients with early detection of certain suggestive, worthy of promotion .